Tilray Canada has launched its newest product, Tilray 2:100, a formulation of therapeutic cannabis oil containing a high concentration of cannabidiol (CBD), which may help treat Canadian patients with conditions like Dravet syndrome.

India Globalisation Capital has been trialling a therapy that can restore memory in mice, promising potential for the treatment of Alzheimer’s.

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED, NYSE: CGC) is pleased to announce that Dr. Mark Ware, a leading researcher in the cannabis field for decades, will join the senior leadership team at Canopy Growth as the Company's Chief Medical Officer commencing July 1st, 2018.

Minister of Industry, Commerce, Agriculture and Fisheries Audley Shaw is confident that the way is now paved for Jamaica to play a leading role in the rapidly growing medical cannabis industry.

According to Shaw, Jamaica is uniquely positioned to bring health and wellness to the world by developing one of its greatest assets, the herbal industry.

Shaw last week met with representatives of the Canadian Government and the Province of Ontario, as well as numerous companies and investors who shared their commitment to investing in the Jamaican cannabis industry.

Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 2 additional Canadian patent applications. Canntab's portfolio now includes 13 patent applications in Canada, the United States and internationally. These filings build on Canntab's growing intellectual property portfolio, which already included patent applications and trademark applications in the United States and Canada.

Zenabis Ltd. (“Zenabis” or “the Company”), a licensed producer of medical cannabis, is pleased to announce that it has received its sales license from Health Canada. The sales license authorizes Zenabis to sell medicinal cannabis online at zenabis.com to registered medical patients across the country.

The addition of the cannabis sales license further solidifies Zenabis’ presence in the Canadian cannabis sector. The Company, which operates more than 400,000 square feet of licensed cannabis cultivation space, now has a fully licensed facility.

We know we’re not supposed to drink alcohol while taking antibiotics. But what about consuming cannabis? Here’s what the experts say.

It is always important to be aware and cautious of what you’re mixing with any sort of medication, since certain medicines will have a negative or more enhanced reaction when taken with another substance. When you’re fighting off a bacterial infection, doctors generally prescribe antibiotics, which come along with some strict rules. But almost never addressed is an important question: can you smoke weed while taking those antibiotics?

When I finished digging through countless studies dealing with health benefits of weed, I only had one question in mind — why are we not using medical cannabis products instead of regular supplements?

In a culture where non-organic multi-vitamins are being mindlessly used (in boatloads) as a “ground breaking prevention for all diseases”, we have decided to limit the public’s access to one thing that actually works.

Even though we’ve heard a lot of bad things about weed in the last 50-70 years, nowadays, after successful efforts by many of its activists, marijuana is believed to help with up to 24 medical conditions.

To confirm this, I went over hundreds of studies and found that there are 16 biggest health benefits of weed that can be backed up by science.

With the legalization of recreational cannabis looming on the horizon, the Canadian Pharmacists Association (CPhA), joined by the Association québécoise des pharmaciens propriétaires (AQPP), appeared today before the Standing Senate Committee on Social Affairs, Science and Technology to discuss Bill C-45. Pharmacists are asking the Senate to include more support for patients who use medical cannabis by ensuring that there is a clear differentiation between the recreational and medical cannabis streams, with incentives for patients to remain in the medical cannabis stream.

A year and a half ago, the Trudeau government rolled back the amount of medical marijuana that it would cover for veterans from 10 grams a day to three.

But that cut may not have been deep enough for at least one member of the Senate sub-committee on Veterans Affairs.

Sen. David Adams Richards said he questioned the maximum daily amount of medical cannabis allotted to vets suffering from conditions such as post-traumatic stress disorder. His concern comes on the heels of testimony by James MacKillop, the director of the Michael G. DeGroote Centre for Medical Cannabis Research at McMaster University.